GI
CELG

GLG Inc’s Celgene Corp CELG Stock Holding History

GLG Inc’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$7.15M Buy
84,632
+73,990
+695% +$5.85M 0.19% 156
2013
Q3 		$819K Hold
10,642
– – 0.02% 596
2013
Q2 		$622K Buy
+10,642
New +$640K 0.02% 533

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLG Inc's CELG Position: Q4 2013 in Review

GLG Inc increased its Celgene Corp (CELG) stake by 695% in Q4 2013, buying an estimated $5.85M and bringing the position to 84,632 shares worth $7.15M. The position accounts for 0.19% of the portfolio, ranked #156.

GLG Inc first reported a position in CELG in Q2 2013 and has held it in 3 quarters since. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • GLG Inc held 84,632 shares of Celgene Corp worth $7.15M as of Q4 2013.
  • GLG Inc bought 73,990 Celgene Corp shares in Q4 2013, an estimated $5.85M.
  • Celgene Corp made up 0.19% of GLG Inc's portfolio in Q4 2013, its #156 holding.
  • GLG Inc first reported a position in Celgene Corp in Q2 2013 and has held it in 3 quarters since.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.